258 related articles for article (PubMed ID: 35921406)
1. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer.
Brown MS; Abdollahi B; Wilkins OM; Lu H; Chakraborty P; Ognjenovic NB; Muller KE; Jolly MK; Christensen BC; Hassanpour S; Pattabiraman DR
Sci Adv; 2022 Aug; 8(31):eabj8002. PubMed ID: 35921406
[TBL] [Abstract][Full Text] [Related]
2. Quantifying epithelial-mesenchymal heterogeneity and EMT scoring in tumor samples via tyramide signal amplification (TSA).
Brown MS; Abdollahi B; Hassanpour S; Pattabiraman DR
Methods Cell Biol; 2022; 171():149-161. PubMed ID: 35953198
[TBL] [Abstract][Full Text] [Related]
3. EMT, cell plasticity and metastasis.
Chaffer CL; San Juan BP; Lim E; Weinberg RA
Cancer Metastasis Rev; 2016 Dec; 35(4):645-654. PubMed ID: 27878502
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression.
Horny K; Sproll C; Peiffer L; Furtmann F; Gerhardt P; Gravemeyer J; Stoecklein NH; Spassova I; Becker JC
J Transl Med; 2023 Apr; 21(1):267. PubMed ID: 37076857
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasis.
Zhang Y; Donaher JL; Das S; Li X; Reinhardt F; Krall JA; Lambert AW; Thiru P; Keys HR; Khan M; Hofree M; Wilson MM; Yedier-Bayram O; Lack NA; Onder TT; Bagci-Onder T; Tyler M; Tirosh I; Regev A; Lees JA; Weinberg RA
Nat Cell Biol; 2022 Apr; 24(4):554-564. PubMed ID: 35411083
[TBL] [Abstract][Full Text] [Related]
6. MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state.
Cui J; Zhang C; Lee JE; Bartholdy BA; Yang D; Liu Y; Erler P; Galbo PM; Hodge DQ; Huangfu D; Zheng D; Ge K; Guo W
Nat Cell Biol; 2023 Jan; 25(1):145-158. PubMed ID: 36604594
[TBL] [Abstract][Full Text] [Related]
7. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
8. A role for kinesin-1 subunits KIF5B/KLC1 in regulating epithelial mesenchymal plasticity in breast tumorigenesis.
Moamer A; Hachim IY; Binothman N; Wang N; Lebrun JJ; Ali S
EBioMedicine; 2019 Jul; 45():92-107. PubMed ID: 31204277
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of p53 function leads to metastatic transcriptome networks that typify tumor progression in human breast cancer xenografts.
D'Assoro AB; Leontovich A; Amato A; Ayers-Ringler JR; Quatraro C; Hafner K; Jenkins RB; Libra M; Ingle J; Stivala F; Galanis E; Salisbury JL
Int J Oncol; 2010 Nov; 37(5):1167-76. PubMed ID: 20878064
[TBL] [Abstract][Full Text] [Related]
10. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
11. Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.
D'Amato NC; Ostrander JH; Bowie ML; Sistrunk C; Borowsky A; Cardiff RD; Bell K; Young LJ; Simin K; Bachelder RE; Delrow J; Dawson A; Yee LD; Mrózek K; Clay TM; Osada T; Seewaldt VL
PLoS One; 2012; 7(9):e45684. PubMed ID: 23049838
[TBL] [Abstract][Full Text] [Related]
12. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
[TBL] [Abstract][Full Text] [Related]
13. Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts.
Tachtsidis A; Le AV; Blick T; Gunasinghe D; De Sousa E; Waltham M; Dobrovic A; Thompson EW
Clin Exp Metastasis; 2019 Aug; 36(4):393-409. PubMed ID: 31190270
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors.
Akrida I; Mulita F; Plachouri KM; Benetatos N; Maroulis I; Papadaki H
Med Oncol; 2023 Dec; 41(1):20. PubMed ID: 38104042
[TBL] [Abstract][Full Text] [Related]
15. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
16. A complex epigenome-splicing crosstalk governs epithelial-to-mesenchymal transition in metastasis and brain development.
Sahu SK; Agirre E; Inayatullah M; Mahesh A; Tiwari N; Lavin DP; Singh A; Strand S; Diken M; Luco RF; Belmonte JCI; Tiwari VK
Nat Cell Biol; 2022 Aug; 24(8):1265-1277. PubMed ID: 35941369
[TBL] [Abstract][Full Text] [Related]
17. Superior breast cancer metastasis risk stratification using an epithelial-mesenchymal-amoeboid transition gene signature.
Emad A; Ray T; Jensen TW; Parat M; Natrajan R; Sinha S; Ray PS
Breast Cancer Res; 2020 Jul; 22(1):74. PubMed ID: 32641077
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA
Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262
[TBL] [Abstract][Full Text] [Related]
19. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
20. Resistance to mesenchymal reprogramming sustains clonal propagation in metastatic breast cancer.
Saini M; Schmidleitner L; Moreno HD; Donato E; Falcone M; Bartsch JM; Klein C; Vogel V; Würth R; Pfarr N; Espinet E; Lehmann M; Königshoff M; Reitberger M; Haas S; Graf E; Schwarzmayr T; Strom TM; Spaich S; Sütterlin M; Schneeweiss A; Weichert W; Schotta G; Reichert M; Aceto N; Sprick MR; Trumpp A; Scheel CH
Cell Rep; 2023 Jun; 42(6):112533. PubMed ID: 37257449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
